Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis. (Q50956468)

26 March 2018

title

Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis. (English)

1 reference

26 March 2018

author name string

Yueqiu Chen

1

1 reference

26 March 2018

Yuxian Song

2

1 reference

26 March 2018

Huishuang Miao

3

1 reference

26 March 2018

Yujun Xu

4

1 reference

26 March 2018

Mingming Lv

5

1 reference

26 March 2018

Tingting Wang

6

1 reference

26 March 2018

Yayi Hou

7

1 reference

26 March 2018

publication date

8 July 2015

1 reference

26 March 2018

published in

Inflammation Research

1 reference

26 March 2018

volume

64

1 reference

26 March 2018

issue

9

1 reference

26 March 2018

page(s)

671-681

1 reference

26 March 2018

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Geographical variability and environmental risk factors in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Innate and adaptive immunity in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Antibodies to interleukin 12 abrogate established experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0845-6

IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

21 January 2018

1 reference

12 December 2020

Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation

1 reference

12 December 2020

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

12 December 2020

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

1 reference

12 December 2020

A novel way to isolate MSCs from umbilical cords

1 reference

12 December 2020

Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response

1 reference

12 December 2020

Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses

1 reference

12 December 2020

IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells

1 reference

12 December 2020

10.1007/S00011-015-0845-6

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018